Click for best price
Biomarker Testing for Cancer Market Size, Share 2023
Cancer markers refer to substances directly produced by tumor cells or induced by non-tumor cells through tumor cells.
This report aims to provide a comprehensive presentation of the global market for Biomarker Testing for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Testing for Cancer. This report contains market size and forecasts of Biomarker Testing for Cancer in global, including the following market information:
Global Biomarker Testing for Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biomarker Testing for Cancer Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Biomarker Testing for Cancer companies in 2022 (%)
The global Biomarker Testing for Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Protein Biomarkers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biomarker Testing for Cancer include F. Hoffmann-L A Roche, Thermo Fisher Scientific, Qiagen N.V., Bio-Rad L aboratories and llumina, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Wesurveyed the Biomarker Testing for Cancer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biomarker Testing for Cancer Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, by Type, 2022 (%)
Protein Biomarkers
Genetic Biomarkers
Others
Global Biomarker Testing for Cancer Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Research & Development
Prognostics
Risk Assessment
Others
Global Biomarker Testing for Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biomarker Testing for Cancer revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biomarker Testing for Cancer revenues share in global market, 2022 (%)
Key companies Biomarker Testing for Cancer sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Biomarker Testing for Cancer sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-L A Roche
Thermo Fisher Scientific
Qiagen N.V.
Bio-Rad L aboratories
llumina
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biomarker Testing for Cancer, market overview.
Chapter 2: Global Biomarker Testing for Cancer market size in revenue and volume.
Chapter 3: Detailed analysis of Biomarker Testing for Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biomarker Testing for Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biomarker Testing for Cancer capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biomarker Testing for Cancer Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
73 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biomarker Testing for Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biomarker Testing for Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biomarker Testing for Cancer Overall Market Size
2.1 Global Biomarker Testing for Cancer Market Size: 2022 VS 2029
2.2 Global Biomarker Testing for Cancer Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biomarker Testing for Cancer Sales: 2018-2029
3 Company Landscape
3.1 Top Biomarker Testing for Cancer Players in Global Market
3.2 Top Global Biomarker Testing for Cancer Companies Ranked by Revenue
3.3 Global Biomarker Testing for Cancer Revenue by Companies
3.4 Global Biomarker Testing for Cancer Sales by Companies
3.5 Global Biomarker Testing for Cancer Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biomarker Testing for Cancer Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biomarker Testing for Cancer Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biomarker Testing for Cancer Players in Global Market
3.8.1 List of Global Tier 1 Biomarker Testing for Cancer Companies
3.8.2 List of Global Tier 2 and Tier 3 Biomarker Testing for Cancer Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biomarker Testing for Cancer Market Size Markets, 2022 & 2029
4.1.2 Protein Biomarkers
4.1.3 Genetic Biomarkers
4.1.4 Others
4.2 By Type - Global Biomarker Testing for Cancer Revenue & Forecasts
4.2.1 By Type - Global Biomarker Testing for Cancer Revenue, 2018-2023
4.2.2 By Type - Global Biomarker Testing for Cancer Revenue, 2024-2029
4.2.3 By Type - Global Biomarker Testing for Cancer Revenue Market Share, 2018-2029
4.3 By Type - Global Biomarker Testing for Cancer Sales & Forecasts
4.3.1 By Type - Global Biomarker Testing for Cancer Sales, 2018-2023
4.3.2 By Type - Global Biomarker Testing for Cancer Sales, 2024-2029
4.3.3 By Type - Global Biomarker Testing for Cancer Sales Market Share, 2018-2029
4.4 By Type - Global Biomarker Testing for Cancer Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biomarker Testing for Cancer Market Size, 2022 & 2029
5.1.2 Diagnostics
5.1.3 Research & Development
5.1.4 Prognostics
5.1.5 Risk Assessment
5.1.6 Others
5.2 By Application - Global Biomarker Testing for Cancer Revenue & Forecasts
5.2.1 By Application - Global Biomarker Testing for Cancer Revenue, 2018-2023
5.2.2 By Application - Global Biomarker Testing for Cancer Revenue, 2024-2029
5.2.3 By Application - Global Biomarker Testing for Cancer Revenue Market Share, 2018-2029
5.3 By Application - Global Biomarker Testing for Cancer Sales & Forecasts
5.3.1 By Application - Global Biomarker Testing for Cancer Sales, 2018-2023
5.3.2 By Application - Global Biomarker Testing for Cancer Sales, 2024-2029
5.3.3 By Application - Global Biomarker Testing for Cancer Sales Market Share, 2018-2029
5.4 By Application - Global Biomarker Testing for Cancer Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Biomarker Testing for Cancer Market Size, 2022 & 2029
6.2 By Region - Global Biomarker Testing for Cancer Revenue & Forecasts
6.2.1 By Region - Global Biomarker Testing for Cancer Revenue, 2018-2023
6.2.2 By Region - Global Biomarker Testing for Cancer Revenue, 2024-2029
6.2.3 By Region - Global Biomarker Testing for Cancer Revenue Market Share, 2018-2029
6.3 By Region - Global Biomarker Testing for Cancer Sales & Forecasts
6.3.1 By Region - Global Biomarker Testing for Cancer Sales, 2018-2023
6.3.2 By Region - Global Biomarker Testing for Cancer Sales, 2024-2029
6.3.3 By Region - Global Biomarker Testing for Cancer Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Biomarker Testing for Cancer Revenue, 2018-2029
6.4.2 By Country - North America Biomarker Testing for Cancer Sales, 2018-2029
6.4.3 US Biomarker Testing for Cancer Market Size, 2018-2029
6.4.4 Canada Biomarker Testing for Cancer Market Size, 2018-2029
6.4.5 Mexico Biomarker Testing for Cancer Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Biomarker Testing for Cancer Revenue, 2018-2029
6.5.2 By Country - Europe Biomarker Testing for Cancer Sales, 2018-2029
6.5.3 Germany Biomarker Testing for Cancer Market Size, 2018-2029
6.5.4 France Biomarker Testing for Cancer Market Size, 2018-2029
6.5.5 U.K. Biomarker Testing for Cancer Market Size, 2018-2029
6.5.6 Italy Biomarker Testing for Cancer Market Size, 2018-2029
6.5.7 Russia Biomarker Testing for Cancer Market Size, 2018-2029
6.5.8 Nordic Countries Biomarker Testing for Cancer Market Size, 2018-2029
6.5.9 Benelux Biomarker Testing for Cancer Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Biomarker Testing for Cancer Revenue, 2018-2029
6.6.2 By Region - Asia Biomarker Testing for Cancer Sales, 2018-2029
6.6.3 China Biomarker Testing for Cancer Market Size, 2018-2029
6.6.4 Japan Biomarker Testing for Cancer Market Size, 2018-2029
6.6.5 South Korea Biomarker Testing for Cancer Market Size, 2018-2029
6.6.6 Southeast Asia Biomarker Testing for Cancer Market Size, 2018-2029
6.6.7 India Biomarker Testing for Cancer Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Biomarker Testing for Cancer Revenue, 2018-2029
6.7.2 By Country - South America Biomarker Testing for Cancer Sales, 2018-2029
6.7.3 Brazil Biomarker Testing for Cancer Market Size, 2018-2029
6.7.4 Argentina Biomarker Testing for Cancer Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biomarker Testing for Cancer Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Biomarker Testing for Cancer Sales, 2018-2029
6.8.3 Turkey Biomarker Testing for Cancer Market Size, 2018-2029
6.8.4 Israel Biomarker Testing for Cancer Market Size, 2018-2029
6.8.5 Saudi Arabia Biomarker Testing for Cancer Market Size, 2018-2029
6.8.6 UAE Biomarker Testing for Cancer Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 F. Hoffmann-L A Roche
7.1.1 F. Hoffmann-L A Roche Company Summary
7.1.2 F. Hoffmann-L A Roche Business Overview
7.1.3 F. Hoffmann-L A Roche Biomarker Testing for Cancer Major Product Offerings
7.1.4 F. Hoffmann-L A Roche Biomarker Testing for Cancer Sales and Revenue in Global (2018-2023)
7.1.5 F. Hoffmann-L A Roche Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Biomarker Testing for Cancer Major Product Offerings
7.2.4 Thermo Fisher Scientific Biomarker Testing for Cancer Sales and Revenue in Global (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Qiagen N.V.
7.3.1 Qiagen N.V. Company Summary
7.3.2 Qiagen N.V. Business Overview
7.3.3 Qiagen N.V. Biomarker Testing for Cancer Major Product Offerings
7.3.4 Qiagen N.V. Biomarker Testing for Cancer Sales and Revenue in Global (2018-2023)
7.3.5 Qiagen N.V. Key News & Latest Developments
7.4 Bio-Rad L aboratories
7.4.1 Bio-Rad L aboratories Company Summary
7.4.2 Bio-Rad L aboratories Business Overview
7.4.3 Bio-Rad L aboratories Biomarker Testing for Cancer Major Product Offerings
7.4.4 Bio-Rad L aboratories Biomarker Testing for Cancer Sales and Revenue in Global (2018-2023)
7.4.5 Bio-Rad L aboratories Key News & Latest Developments
7.5 llumina
7.5.1 llumina Company Summary
7.5.2 llumina Business Overview
7.5.3 llumina Biomarker Testing for Cancer Major Product Offerings
7.5.4 llumina Biomarker Testing for Cancer Sales and Revenue in Global (2018-2023)
7.5.5 llumina Key News & Latest Developments
8 Global Biomarker Testing for Cancer Production Capacity, Analysis
8.1 Global Biomarker Testing for Cancer Production Capacity, 2018-2029
8.2 Biomarker Testing for Cancer Production Capacity of Key Manufacturers in Global Market
8.3 Global Biomarker Testing for Cancer Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biomarker Testing for Cancer Supply Chain Analysis
10.1 Biomarker Testing for Cancer Industry Value Chain
10.2 Biomarker Testing for Cancer Upstream Market
10.3 Biomarker Testing for Cancer Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biomarker Testing for Cancer Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biomarker Testing for Cancer in Global Market
Table 2. Top Biomarker Testing for Cancer Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biomarker Testing for Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biomarker Testing for Cancer Revenue Share by Companies, 2018-2023
Table 5. Global Biomarker Testing for Cancer Sales by Companies, (K Units), 2018-2023
Table 6. Global Biomarker Testing for Cancer Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biomarker Testing for Cancer Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Biomarker Testing for Cancer Product Type
Table 9. List of Global Tier 1 Biomarker Testing for Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biomarker Testing for Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biomarker Testing for Cancer Sales (K Units), 2018-2023
Table 15. By Type - Global Biomarker Testing for Cancer Sales (K Units), 2024-2029
Table 16. By Application ? Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biomarker Testing for Cancer Sales (K Units), 2018-2023
Table 20. By Application - Global Biomarker Testing for Cancer Sales (K Units), 2024-2029
Table 21. By Region ? Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biomarker Testing for Cancer Sales (K Units), 2018-2023
Table 25. By Region - Global Biomarker Testing for Cancer Sales (K Units), 2024-2029
Table 26. By Country - North America Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biomarker Testing for Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biomarker Testing for Cancer Sales, (K Units), 2018-2023
Table 29. By Country - North America Biomarker Testing for Cancer Sales, (K Units), 2024-2029
Table 30. By Country - Europe Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biomarker Testing for Cancer Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biomarker Testing for Cancer Sales, (K Units), 2018-2023
Table 33. By Country - Europe Biomarker Testing for Cancer Sales, (K Units), 2024-2029
Table 34. By Region - Asia Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biomarker Testing for Cancer Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biomarker Testing for Cancer Sales, (K Units), 2018-2023
Table 37. By Region - Asia Biomarker Testing for Cancer Sales, (K Units), 2024-2029
Table 38. By Country - South America Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biomarker Testing for Cancer Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biomarker Testing for Cancer Sales, (K Units), 2018-2023
Table 41. By Country - South America Biomarker Testing for Cancer Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biomarker Testing for Cancer Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biomarker Testing for Cancer Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Biomarker Testing for Cancer Sales, (K Units), 2024-2029
Table 46. F. Hoffmann-L A Roche Company Summary
Table 47. F. Hoffmann-L A Roche Biomarker Testing for Cancer Product Offerings
Table 48. F. Hoffmann-L A Roche Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. F. Hoffmann-L A Roche Key News & Latest Developments
Table 50. Thermo Fisher Scientific Company Summary
Table 51. Thermo Fisher Scientific Biomarker Testing for Cancer Product Offerings
Table 52. Thermo Fisher Scientific Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Thermo Fisher Scientific Key News & Latest Developments
Table 54. Qiagen N.V. Company Summary
Table 55. Qiagen N.V. Biomarker Testing for Cancer Product Offerings
Table 56. Qiagen N.V. Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Qiagen N.V. Key News & Latest Developments
Table 58. Bio-Rad L aboratories Company Summary
Table 59. Bio-Rad L aboratories Biomarker Testing for Cancer Product Offerings
Table 60. Bio-Rad L aboratories Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Bio-Rad L aboratories Key News & Latest Developments
Table 62. llumina Company Summary
Table 63. llumina Biomarker Testing for Cancer Product Offerings
Table 64. llumina Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. llumina Key News & Latest Developments
Table 66. Biomarker Testing for Cancer Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Biomarker Testing for Cancer Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Biomarker Testing for Cancer Production by Region, 2018-2023 (K Units)
Table 69. Global Biomarker Testing for Cancer Production by Region, 2024-2029 (K Units)
Table 70. Biomarker Testing for Cancer Market Opportunities & Trends in Global Market
Table 71. Biomarker Testing for Cancer Market Drivers in Global Market
Table 72. Biomarker Testing for Cancer Market Restraints in Global Market
Table 73. Biomarker Testing for Cancer Raw Materials
Table 74. Biomarker Testing for Cancer Raw Materials Suppliers in Global Market
Table 75. Typical Biomarker Testing for Cancer Downstream
Table 76. Biomarker Testing for Cancer Downstream Clients in Global Market
Table 77. Biomarker Testing for Cancer Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biomarker Testing for Cancer Segment by Type in 2022
Figure 2. Biomarker Testing for Cancer Segment by Application in 2022
Figure 3. Global Biomarker Testing for Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biomarker Testing for Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biomarker Testing for Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. Biomarker Testing for Cancer Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biomarker Testing for Cancer Revenue in 2022
Figure 9. By Type - Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biomarker Testing for Cancer Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biomarker Testing for Cancer Sales Market Share, 2018-2029
Figure 12. By Type - Global Biomarker Testing for Cancer Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biomarker Testing for Cancer Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biomarker Testing for Cancer Sales Market Share, 2018-2029
Figure 16. By Application - Global Biomarker Testing for Cancer Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biomarker Testing for Cancer Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biomarker Testing for Cancer Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biomarker Testing for Cancer Sales Market Share, 2018-2029
Figure 21. By Country - North America Biomarker Testing for Cancer Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biomarker Testing for Cancer Sales Market Share, 2018-2029
Figure 23. US Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biomarker Testing for Cancer Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biomarker Testing for Cancer Sales Market Share, 2018-2029
Figure 28. Germany Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. France Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biomarker Testing for Cancer Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biomarker Testing for Cancer Sales Market Share, 2018-2029
Figure 37. China Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. India Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biomarker Testing for Cancer Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biomarker Testing for Cancer Sales Market Share, 2018-2029
Figure 44. Brazil Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biomarker Testing for Cancer Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biomarker Testing for Cancer Sales Market Share, 2018-2029
Figure 48. Turkey Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biomarker Testing for Cancer Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biomarker Testing for Cancer Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Biomarker Testing for Cancer by Region, 2022 VS 2029
Figure 54. Biomarker Testing for Cancer Industry Value Chain
Figure 55. Marketing Channels
